Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
A practical guide to selecting between total market and total world funds for retirement, focusing on goals, risk tolerance, and costs.
28,577 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
A historic heat dome pushed the PJM grid toward an all-time peak. This investing backdrop highlights four power stock...
Ripple gains a foothold in the core clearing network as NSCC lists a Ripple-linked entity. The move aligns with Rippl...
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
South Korea’s Kospi surged about 8% as investors chased growth stocks amid a debt-fueled rally. A Samsung labor deal ...
The Nasdaq trades near flat as investors weigh a Middle East deal and a SpaceX IPO. Markets face a cautious open as e...
Broadcom inks a long-term extension with Apple through 2031, tying roughly 20% of AVGO's annual sales to the iPhone m...
An overlooked defense contractor pivots to AI, turning years of skepticism into a rising star in enterprise AI and de...
An investor explains a dip‑buying method focused on Nvidia, detailing how long‑term AI demand and enterprise commitme...
A prominent crypto trader files a lawsuit against Coinbase claiming it refused to return DAI funds stolen in a phishi...
NovaTech Corp announced a 4,000-job layoff as it pivots to AI-powered operations, boosting stock for now while intens...
Investors are shifting perspective on semiconductors, treating chips like commodities amid AI-driven demand and suppl...